Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q39010445)
Watch
English
FGFR-TACC gene fusions in human glioma
scientific article published on 16 November 2016
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
5464372
retrieved
17 June 2018
reference URL
http://europepmc.org/abstract/PMC/5464372
review article
1 reference
stated in
Europe PubMed Central
title
FGFR-TACC gene fusions in human glioma
(English)
1 reference
stated in
Europe PubMed Central
PMCID
5464372
retrieved
17 June 2018
reference URL
http://europepmc.org/abstract/PMC/5464372
author
Anna Lasorella
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
Antonio Iavarone
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
author name string
Marc Sanson
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
publication date
1 April 2017
1 reference
stated in
Europe PubMed Central
PMCID
5464372
retrieved
17 June 2018
reference URL
http://europepmc.org/abstract/PMC/5464372
published in
Neuro-Oncology
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
volume
19
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
page(s)
475-483
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
issue
4
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
cites work
Clonal evolution of glioblastoma under therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other Malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Targeting the fibroblast growth factor receptor family in cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
FGFR3-TACC3: A novel gene fusion in cervical cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
CNS Anticancer Drug Discovery and Development Conference White Paper.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
High levels of c-Met is associated with poor prognosis in glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Coiled-coil coactivators play a structural role mediating interactions in hypoxia-inducible factor heterodimerization
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The landscape and therapeutic relevance of cancer-associated transcript fusions.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Molecular and cellular heterogeneity: the hallmark of glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The landscape of kinase fusions in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Deep molecular response in chronic myeloid leukemia: the new goal of therapy?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Identification of targetable FGFR gene fusions in diverse cancers.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Oncogenic FGFR3 gene fusions in bladder cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Transforming fusions of FGFR and TACC genes in human glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Pulling it together: The mitotic function of TACC3.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
ALK-targeted therapy for lung cancer: ready for prime time.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Residual tumor cells are unique cellular targets in glioblastoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Fibroblast growth factor signalling: from development to cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Complex landscapes of somatic rearrangement in human breast cancer genomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Oncogenic gene fusions in epithelial carcinomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The TACC proteins: TACC-ling microtubule dynamics and centrosome function
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Designing phase 0 cancer clinical trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The development of phase I cancer trial methodologies: the use of pharmacokinetic and pharmacodynamic end points sets the scene for phase 0 cancer clinical trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Aneuploidy: cells losing their balance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Phase 0 clinical trials: conceptions and misconceptions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
EML4-ALK fusion lung cancer: a rare acquired event
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The impact of translocations and gene fusions on cancer causation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Functions and regulations of fibroblast growth factor signaling during embryonic development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Cellular signaling by fibroblast growth factor receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
22 June 2018
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
21 August 2018
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
21 August 2018
FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
21 August 2018
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
21 August 2018
Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
21 August 2018
Disruption of Tacc3 function leads to in vivo tumor regression.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
21 August 2018
Compressing drug development timelines in oncology using phase '0' trials.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464372
retrieved
21 August 2018
Management of intracranial aneurysms associated with arteriovenous malformations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1093%2FNEUONC%2FNOW240
retrieved
21 January 2018
Identifiers
DOI
10.1093/NEUONC/NOW240
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
PMCID
5464372
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
PubMed ID
27852792
1 reference
stated in
Europe PubMed Central
PMCID
5464372
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27852792%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 June 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
